Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma

Biochim Biophys Acta Mol Basis Dis. 2024 Apr;1870(4):167054. doi: 10.1016/j.bbadis.2024.167054. Epub 2024 Feb 13.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors and is a serious threat to human health; thus, early diagnosis and adequate treatment are essential. However, there are still great challenges in identifying the tipping point and detecting early warning signals of early HCC. In this study, we aimed to identify the tipping point (critical state) of and key molecules involved in hepatocarcinogenesis based on time series transcriptome expression data of HCC patients. The phase from veHCC (very early HCC) to eHCC (early HCC) was identified as the critical state in HCC progression, with 143 genes identified as key candidate molecules by combining the DDRTree (dimensionality reduction via graph structure learning) and DNB (dynamic network biomarker) methods. Then, we ranked the candidate genes to verify their mRNA levels using the diethylnitrosamine (DEN)-induced HCC mouse model and identified five early warning signals, namely, CCT3, DSTYK, EIF3E, IARS2 and TXNRD1; these signals can be regarded as the potential early warning signals for the critical state of HCC. We identified CCT3 as an independent prognostic factor for HCC, and functions of CCT3 involving in the "MYCtargets_V1" and "E2F-Targets" are closely related to the progression of HCC. The predictive method combining the DDRTree and DNB methods can not only identify the key critical state before cancer but also determine candidate molecules of critical state, thus providing new insight into the early diagnosis and preemptive treatment of HCC.

Keywords: Critical state; DDRTree; DNB; Early warning signals; Hepatocellular carcinoma.

MeSH terms

  • Animals
  • Biomarkers
  • Carcinogenesis / genetics
  • Carcinogenesis / pathology
  • Carcinoma, Hepatocellular* / diagnosis
  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / metabolism
  • Chaperonin Containing TCP-1 / genetics
  • Chaperonin Containing TCP-1 / metabolism
  • Humans
  • Liver Neoplasms* / pathology
  • Mice
  • Receptor-Interacting Protein Serine-Threonine Kinases / genetics
  • Transcriptome

Substances

  • Biomarkers
  • DSTYK protein, human
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • CCT3 protein, human
  • Chaperonin Containing TCP-1